We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. “In this final follow-up from the SIMPLICITY HTN-3 trial ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. WASHINGTON — In patients with treatment-resistant ...

A radiofrequency-based renal denervation system for uncontrolled hypertension got a cool reception from FDA advisors who nevertheless left the door open for regulatory approval. On Wednesday, the ...

The treatment of resistant hypertension has received a boost with the recent US Food and Drug Administration (FDA) approval of a completely new therapeutic approach that reduces activity in the ...

National coverage analysis is the first-of-its kind for a minimally invasive, interventional treatment for high blood pressure Milestone is supported by large public health need and robust, long-term ...

Medtronic and Recor Medical stand to benefit from national Medicare coverage for their new device-based treatments for patients with uncontrolled high blood pressure. Medtronic and Recor have had ...

Renal denervation using radiofrequency energy is a cost-effective and high-value intervention for the treatment of uncontrolled hypertension from the perspective of the US healthcare system, an ...

Catheter-based, radiofrequency renal denervation is a cost-effective solution for patients with hypertension, according to a study published Aug. 13 in the Journal of the Society for Cardiovascular ...

Renal denervation delivers radiofrequency energy to overactive nerves in renal arteries and branch vessels. Renal denervation along with use of antihypertensive drugs leads to a sustained reduction in ...